𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of factor VIII deficiency on clotting factor utilization in the United States

✍ Scribed by Louis M. Aledort; Scott H. Goodnight; A. Vuaya Rao; Jan Schwarz; Deborah Whitehurst; Sandor S. Shapiro; Hemophilia Study Group

Publisher
Springer
Year
1983
Tongue
English
Weight
589 KB
Volume
13
Category
Article
ISSN
0940-5437

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Liver-restricted expression of the canin
Liver-restricted expression of the canine factor VIII gene facilitates prevention of inhibitor formation in factor VIII-deficient mice
✍ Akira Ishiwata; Jun Mimuro; Hiroaki Mizukami; Yuji Kashiwakura; Katsuhiro Takano πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 341 KB

## Abstract ## Background Gene therapy for hemophilia A with adeno‐associated virus (AAV) vectors involves difficulties in the efficient expression of factor VIII (FVIII) and in antibody formation against transgene‐derived FVIII. ## Methods AAV8 vectors carrying the canine B domain deleted FVIII

The economic impact of factor VIII inhib
The economic impact of factor VIII inhibitors in patients with haemophilia
✍ R. L. Bohn; L. M. Aledort; K. G. Putnam; B. M. Ewenstein; H. Mogun; J. Avorn πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 61 KB

**Summary.** The impact on the cost of care for haemophilia patients with inhibitors is not well defined. To quantify the effect on health care expenditures associated with inhibitors to factor VIII (FVIII) or FIX, we conducted a retrospective cohort study examining product use and outcomes in adult